Publication for Klf4 and Thbd
Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
---|---|---|---|---|---|---|
mmu | Klf4 | Kruppel-like factor 4 (gut) | 16600 | [link] | ||
mmu | Thbd | thrombomodulin | 21824 |
Pubmed ID | Priority | Text |
---|---|---|
26634653 | 0.98 | KLF4 or both markedly attenuated Nor1-induced TM expression in ECs (Figure 3D), further suggesting that Nor1 increases TM expression through inducing KLF2 and KLF4 transcriptional activities in vascular ECs. |
0.98 | KLF4 have been shown to play essential roles in the regulation of TM expression at transcriptional levels. | |
0.98 | TM promoter activity indirectly through induction of both KLF2 and KLF4 in ECs. | |
0.97 | TM expression predominantly through increasing TM mRNA stability, while Nor1 involves an induction of KLF2 and KLF4 in ECs. | |
0.69 | KLF4 attenuates Nor1-induced TM expression. | |
24526695 | 0.98 | KLF4 interact with the cofactor p300 to augment transcription of eNOS and thrombomodulin. |
0.98 | KLF4 are potent inducers of eNOS and thrombomodulin expression and also inhibit cytokine-induced expression of adhesion factors-including VCAM-1, E-selectin- and other inflammatory mediators . | |
0.98 | KLF4 increase thrombomodulin and tissue plasminogen activator expression (tPA) and decrease plasminogen activator inhibitor (PAI-1) and cytokine-stimulated tissue factor expression , consistent with an anti-thrombotic effect. | |
30660098 | 0.98 | KLF4 induced the expression of its known target genes eNOS, argininosuccinate synthetase1 (ASS1) and thrombomodulin. |
0.98 | KLF4 attenuated NF-kappaB activity and inhibited the expression of vascular cell adhesion molecule-1 (VCAM-1) and plasminogen activator inhibitor-1 (PAI-1); KLF4 also induces the gene expression of eNOS and thrombomodulin to maintain endothelium under an anti-adhesive and anti-thrombotic state. | |
0.98 | KLF4 leads to decreased expression of its target genes eNOS, ASS1 and thrombomodulin (Fig. 2), which might impair the protective effects of KLF4. | |
25625206 | 0.98 | Klf4 and a number of known KLF2/4 target genes, including Nos3, Aqp1, Jam2, Thbd, and Palmd (Fig. 3A, B & D). |
0.98 | Thbd, and Palmd, as well as Klf4, Adamts4 and Adamts5 (Fig. 5C, D). | |
20724706 | 0.98 | KLF4 in ECs under physiologic conditions, and elevated expression of KLF4 in cultured ECs induced the expression of several anti-inflammatory and anti-thrombotic factors, notably endothelial nitric oxide synthase (eNOS) and thrombomodulin (TM). |
29459900 | 0.98 | KLF4 overexpression also increases transcription of anti-thrombotic factor thrombomodulin as well via a physical association with its cofactor, p. 300. |
31387590 | 0.98 | KLF-4 further modulates downstream molecules, including NOS3, TM, and MCP-1. |
27901106 | 0.97 | KLF4, KLF10, FOSL2, SERPINE1, THBD, MEF2D, and MAFF, showed a clear correlation with increased levels of PIM1/2 (Fig. 7C and D). |
0.78 | KLF4, KLF10, FOSL2, SERPINE1, THBD, MEF2D, and MAFF. | |
29984197 | 0.93 | KLF4, eNOS, and thrombomodulin, while increasing MCP-1. |
The preparation time of this page was 0.0 [sec].